NLRP6 function in inflammatory monocytes reduces susceptibility to chemically induced intestinal injury

Mucosal Immunology

Volumn 10, Issue 2, 2017, Pages 434-445

  Seregin, S S ^a   Golovchenko, N ^a   Schaf, B ^a   Chen, J ^a   Eaton, K A ^a   Chen, G Y ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEXTRAN SULFATE; INTERLEUKIN 18; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PROTEIN NLRP6; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; LY ANTIGEN; LY-6C ANTIGEN, MOUSE; NOD-LIKE RECEPTOR PYRIN DOMAIN-CONTAINING PROTEIN 6, MOUSE;

ADOPTIVE TRANSFER; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CELL PROTECTION; CHRONIC INFLAMMATION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; INFLAMMATORY CELL; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; MONOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; DISEASE PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; INTESTINE; KNOCKOUT MOUSE; METABOLISM; MUCOSA; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, LY; CELLS, CULTURED; COLITIS; DEXTRAN SULFATE; DISEASE SUSCEPTIBILITY; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-18; INTESTINES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MONOCYTES; MUCOUS MEMBRANE; RECEPTORS, CELL SURFACE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85014547105     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2016.55     Document Type: Article

References (45)

1. Chen, G.Y., Liu, M., Wang, F., Bertin, J. & Nunez, G. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J. Immunol. 186, 7187-7194 (2011).
2. Chen, G.Y. Role of Nlrp6 and Nlrp12 in the maintenance of intestinal homeostasis. Eur. J. Immunol. 44, 321-327 (2013).
3. Elinav E. et al., NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis, Cell, 2011, 145, 745-757
4. Normand, S. et al. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc. Natl. Acad. Sci. USA 108, 9601-9606 (2011).
5. Allen, I.C. et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-Associated cancer. J. Exp. Med. 207, 1045-1056 (2010).
6. Zaki, M.H., Boyd, K.L., Vogel, P., Kastan, M.B., Lamkanfi, M.& Kanneganti, T.D. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32, 379-391 (2010).
7. Wlodarska, M. et al. NLRP6 inflammasome orchestrates the colonic hostmicrobial interface by regulating goblet cell mucus secretion. Cell 156, 1045-1059 (2014).
8. Gordon, S. & Taylor, P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964 (2005).
9. Zigmond, E. et al. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 37, 1076-1090 (2012).
10. Sherwood, R.A. Faecal markers of gastrointestinal inflammation. J. Clin. Pathol. 65, 981-985 (2012).
11. Murray, P.J. & Wynn, T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723-737 (2011).
12. Anand, P.K. et al. NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature 488, 389-393 (2012).
13. Kempster, S.L. et al. Developmental control of the Nlrp6 inflammasome and a substrate, IL-18, in mammalian intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G253-G263 (2010).
14. Reinecker, H.C. et al. Enhanced secretion of tumour necrosis factor-Alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohns disease. Clin. Exp. Immunol. 94, 174-181 (1993).
15. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241 (2004).
16. Pizarro, T.T. et al. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohns disease: expression and localization in intestinal mucosal cells. J. Immunol. 162, 6829-6835 (1999).
17. Furuya, D. et al. Serum interleukin-18 concentrations in patients with inflammatory bowel disease. J. Immunother. 25, S65-S67 (2002).
18. Salcedo, R. et al. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J. Exp. Med. 207, 1625-1636 (2010).
19. Siegmund, B. Interleukin-18 in intestinal inflammation: friend and foe? Immunity 32, 300-302 (2010).
20. Dupaul-Chicoine, J. et al. Control of intestinal homeostasis, colitis, and colitis-Associated colorectal cancer by the inflammatory caspases. Immunity 32, 367-378 (2010).
21. Huber, S. et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 491, 259-263 (2012).
22. Naito, Y. et al. Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-Alpha deficient mice. J. Gastroenterol. Hepatol. 18, 560-569 (2003).
23. Noti, M., Corazza, N., Mueller, C., Berger, B. & Brunner, T. TNF suppresses acute intestinal inflammation by inducing local glucocorticoid synthesis. J. Exp. Med. 207, 1057-1066 (2010).
24. Wang, Y. et al. Protective role of tumor necrosis factor (TNF) receptors in chronic intestinal inflammation: TNFR1 ablation boosts systemic inflammatory response. Lab. Invest. 93, 1024-1035 (2013).
25. Zhan, Y. et al. Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury. Cancer Res. 73, 7199-7210 (2013).
26. Edelblum, K.L., Goettel, J.A., Koyama, T., McElroy, S.J., Yan, F. & Polk, D.B. TNFR1 promotes tumor necrosis factor-mediated mouse colon epithelial cell survival through RAF activation of NF-kappaB. J. Biol. Chem. 283, 29485-29494 (2008).
27. Feng, Y. & Teitelbaum, D.H. Tumour necrosis factor-induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition. J. Physiol. 591, 3709-3723 (2013).
28. Stillie, R. & Stadnyk, A.W. Role of TNF receptors, TNFR1 and TNFR2, in dextran sodium sulfate-induced colitis. Inflamm. Bowel Dis. 15, 1515-1525 (2009).
29. Wang, K. et al. Opposite role of tumor necrosis factor receptors in dextran sulfate sodium-induced colitis in mice. PLoS One 7, e52924 (2012).
30. Naude, P.J., den Boer, J.A., Luiten, P.G. & Eisel, U.L. Tumor necrosis factor receptor cross-Talk. FEBS J. 278, 888-898 (2011).
31. Hijdra, D., Vorselaars, A.D., Grutters, J.C., Claessen, A.M. & Rijkers, G.T. Differential expression of TNFR1 (CD120a) and TNFR2 (CD120b) on subpopulations of human monocytes. J. Inflamm. (Lond) 9, 38 (2012).
32. Greten, F.R. et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-Associated cancer. Cell 118, 285-296 (2004).
33. Bain, C.C. &Mowat, A.M. Themonocyte-macrophage axis in the intestine. Cell Immunol. 291, 41-48 (2014).
34. Bain, C.C. & Mowat, A.M. Macrophages in intestinal homeostasis and inflammation. Immunol. Rev. 260, 102-117 (2014).
35. Bain, C.C. et al. Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol. 6, 498-510 (2013).
36. Varol, C., Zigmond, E. & Jung, S. Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria. Nat. Rev. Immunol. 10, 415-426 (2010).
37. Qualls, J.E., Kaplan, A.M., van Rooijen, N. & Cohen, D.A. Suppression of experimental colitis by intestinal mononuclear phagocytes. J. Leukoc. Biol. 80, 802-815 (2006).
38. Molloy, M.J. et al. Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. Cell Host Microbe 14, 318-328 (2013).
39. Bayir, H. Reactive oxygen species. Crit. CareMed. 33, S498-S501 (2005).
40. Nakanishi, K., Yoshimoto, T., Tsutsui, H. & Okamura, H. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19, 423-474 (2001).
41. Dai, S.M., Matsuno, H., Nakamura, H., Nishioka, K. & Yudoh, K. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis. Arthritis Rheum. 50, 432-443 (2004).
42. Dias-Melicio, L.A., Fernandes, R.K., Rodrigues, D.R., Golim, M.A. & Soares, A.M. Interleukin-18 increases TLR4 and mannose receptor expression and modulates cytokine production in human monocytes. Mediators Inflamm. 2015, 236839 (2015).
43. Ahmadian, M. et al. PPARgamma signaling andmetabolism: The good, the bad and the future. Nat. Med. 19, 557-566 (2013).
44. Adachi, M. et al. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut 55, 1104-1113 (2006).
45. Shah, Y.M., Morimura, K. & Gonzalez, F.J. Expression of peroxisome proliferator-Activated receptor-gamma in macrophage suppresses experimentally induced colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G657-G666 (2007).